Similar articles

• Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites.

  Miyake T, Yamamoto T, Hirai Y, Otsuka M, Hamada T, Tsuji K, Morizane S, Suzuki D, Aoyama Y, Iwatsuki K. Miyake T, et al. Br J Dermatol. 2015 Jan;172(1):56-63. doi: 10.1111/bjd.13411. Epub 2014 Dec 10. Br J Dermatol. 2015. PMID: 25234411
• The aim of the measurement of Epstein-Barr virus DNA in hydroa vacciniforme and hypersensitivity to mosquito bites.

  Miyake T, Iwatsuki K, Hirai Y, Yamamoto T, Hamada T, Fujii K, Imamura H, Morizane S. Miyake T, et al. J Med Virol. 2020 Dec;92(12):3689-3696. doi: 10.1002/jmv.25811. Epub 2020 Apr 25. J Med Virol. 2020. PMID: 32255500
• Characterization of Epstein-Barr virus-infected natural killer lymphocytes in a patient with hypersensitivity to mosquito bites.

  Yamamoto T, Fujii K, Tsuji K, Akazai A, Oda M, Imai S, Iwatsuki K. Yamamoto T, et al. J Am Acad Dermatol. 2005 Nov;53(5):912-4. doi: 10.1016/j.jaad.2005.05.002. J Am Acad Dermatol. 2005. PMID: 16243163 No abstract available.
• Hypersensitivity to mosquito bites is not an allergic disease, but an Epstein-Barr virus-associated lymphoproliferative disease.

  Ishihara S, Yabuta R, Tokura Y, Ohshima K, Tagawa S. Ishihara S, et al. Int J Hematol. 2000 Aug;72(2):223-8. Int J Hematol. 2000. PMID: 11039673 Review.
• Hypersensitivity to mosquito bites: a unique pathogenic mechanism linking Epstein-Barr virus infection, allergy and oncogenesis.

  Asada H. Asada H. J Dermatol Sci. 2007 Mar;45(3):153-60. doi: 10.1016/j.jdermsci.2006.11.002. Epub 2006 Dec 13. J Dermatol Sci. 2007. PMID: 17169531 Review.